A novel Peptamen-based enteral nutrition protocol for treatment of Crohn s disease A Pilot Trial


The purpose of this study is to evaluate the therapeutic feasibility of a Peptamen-based, oral nutrition dietary regimen for treatment of adult Crohn’s disease. Specifically we are evaluating if consuming 80-100% of caloric needs from Peptamen 1.5 for 4 weeks is feasible for the potential future use therapeutically in adult Crohn’s disease.

I'm interested

18 Years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:
? 18-89 years of age ? Diagnosis of Crohn's disease ? Moderate to severe Crohn's disease on current therapy
Exclusion Criteria:
? Diagnosis of short bowel syndrome ? Presence of ileostomy or colostomy ? Chronic Kidney Disease Stage III-V

Digestive & Liver Health, Microbiota

Crohn?s disease, IBD, dietary intervention, enteral nutrition, inflammatory bowel disease
Byron Vaughn